BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11181883)

  • 1. Neuropsychological functioning of youths with sickle cell disease: comparison with non-chronically ill peers.
    Noll RB; Stith L; Gartstein MA; Ris MD; Grueneich R; Vannatta K; Kalinyak K
    J Pediatr Psychol; 2001 Mar; 26(2):69-78. PubMed ID: 11181883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological functioning in preschool-age children with sickle cell disease: the role of illness-related and psychosocial factors.
    Tarazi RA; Grant ML; Ely E; Barakat LP
    Child Neuropsychol; 2007 Mar; 13(2):155-72. PubMed ID: 17364572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children.
    Ruffieux N; Njamnshi AK; Wonkam A; Hauert CA; Chanal J; Verdon V; Fonsah JY; Eta SC; Doh RF; Ngamaleu RN; Kengne AM; Fossati C; Sztajzel R
    Child Neuropsychol; 2013; 19(2):143-60. PubMed ID: 22176123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging.
    Gold JI; Johnson CB; Treadwell MJ; Hans N; Vichinsky E
    Pediatr Hematol Oncol; 2008 Jun; 25(5):409-21. PubMed ID: 18569843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease.
    Brown RT; Davis PC; Lambert R; Hsu L; Hopkins K; Eckman J
    J Pediatr Psychol; 2000; 25(7):503-13. PubMed ID: 11007807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease.
    DeBaun MR; Schatz J; Siegel MJ; Koby M; Craft S; Resar L; Chu JY; Launius G; Dadash-Zadeh M; Lee RB; Noetzel M
    Neurology; 1998 Jun; 50(6):1678-82. PubMed ID: 9633710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive deficits in children with sickle cell disease: a comprehensive profile.
    Hijmans CT; Fijnvandraat K; Grootenhuis MA; van Geloven N; Heijboer H; Peters M; Oosterlaan J
    Pediatr Blood Cancer; 2011 May; 56(5):783-8. PubMed ID: 21370411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive functioning in children with sickle cell disease: a meta-analysis.
    Schatz J; Finke RL; Kellett JM; Kramer JH
    J Pediatr Psychol; 2002 Dec; 27(8):739-48. PubMed ID: 12403864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits associated with frontal-lobe infarction in children with sickle cell disease.
    Watkins KE; Hewes DK; Connelly A; Kendall BE; Kingsley DP; Evans JE; Gadian DG; Vargha-Khadem F; Kirkham FJ
    Dev Med Child Neurol; 1998 Aug; 40(8):536-43. PubMed ID: 9746006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive function performance on the children's kitchen task assessment with children with sickle cell disease and matched controls.
    Berg C; Edwards DF; King A
    Child Neuropsychol; 2012; 18(5):432-48. PubMed ID: 21961955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for cognitive rehabilitation for children with sickle cell disease and strokes.
    King AA; DeBaun MR; White DA
    Expert Rev Neurother; 2008 Feb; 8(2):291-6. PubMed ID: 18271713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia.
    Hijmans CT; Grootenhuis MA; Oosterlaan J; Heijboer H; Peters M; Fijnvandraat K
    Pediatr Blood Cancer; 2011 Aug; 57(2):297-302. PubMed ID: 21671366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease.
    Schatz J; Finke R; Roberts CW
    J Dev Behav Pediatr; 2004 Oct; 25(5):303-10. PubMed ID: 15502546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic predictors of neurocognitive functioning in pediatric Sickle Cell disease.
    Kral MC; Brown RT; Connelly M; Curé JK; Besenski N; Jackson SM; Abboud MR
    J Child Neurol; 2006 Jan; 21(1):37-44. PubMed ID: 16551451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance-based everyday functioning after stroke: relationship with IADL questionnaire and neurocognitive performance.
    Sadek JR; Stricker N; Adair JC; Haaland KY
    J Int Neuropsychol Soc; 2011 Sep; 17(5):832-40. PubMed ID: 21880170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental Outcomes in Preterm Children with Sickle Cell Disease.
    Bills SE; Schatz J; Hunt E; Varanasi S; Johnston J; Bradshaw J
    J Int Neuropsychol Soc; 2022 Nov; 28(10):1039-1049. PubMed ID: 34839840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease.
    Puffer E; Schatz J; Roberts CW
    Child Neuropsychol; 2007 Mar; 13(2):142-54. PubMed ID: 17364571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in Children With Sickle Cell Disease: Association With Neurocognitive and Social-Emotional Functioning and Quality of Life.
    Anderson LM; Allen TM; Thornburg CD; Bonner MJ
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):584-9. PubMed ID: 26479993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of structural magnetic resonance imaging, magnetic resonance perfusion, and other disease factors to neuropsychological outcome in sickle cell disease.
    Grueneich R; Ris MD; Ball W; Kalinyak KA; Noll R; Vannatta K; Wells R
    J Pediatr Psychol; 2004 Mar; 29(2):83-92. PubMed ID: 15096530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academic performance in Jamaican children with sickle cell disease.
    King LG; Ali SB; Chang SM; Reid ME; Soares DP
    J Natl Med Assoc; 2023 Oct; 115(5):475-481. PubMed ID: 37550160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.